The catch is the difference between sales and revenues. Generics will continue to be a force, and small-audience drugs will become increasingly important.
A wide-ranging piece recounts the pushback from oncologists that led to a decrease in the price of Zaltrap.
GlaxoSmithKline second-quarter sales rose 2% over the same period last year. CEO Andrew Witty says it is too early to tally the impact of China's corruption allegations.
GlaxoSmithKline says it is scaling back on acquisitions; Sanofi's CEO picks a regulatory fight; Maine wants to allow Ex-US meds; and New York State seeks to empower pharmacists.
CEO Alex Gorsky said OTC brands are coming back. Meanwhile, pharmaceutical sales provided ballast to the year's numbers.
Last year, a wave of new products brought the industry succor as it awaits the full impact of the patent cliff on blockbuster brands. But companies should brace for contraction.
GlaxoSmithKline is building its first new UK factory in almost 40 years, the firm said, spurring jobs while breaking new ground at some of its current locations.
Branded drug sales declined 0.7% to $229 billion last year, according to IMS Health, and that's having an impact on promotional spend.
Pfizer may be headed toward a major restructuring that could include the sale of some of its most enduring brands, an analyst says.
Abbott Labs' US pharmaceuticals business is undergoing some hefty changes: about 1,500 layoffs, a merger with the international division and the retirement of its SVP.
A federal appeals court on Tuesday reversed a district court ruling that limited the use of prescriber-identifiable data in Vermont, signaling a victory for plaintiffs IMS Health, SDI and Wolters Kluwer Health.
Roche detailed its "operational excellence" cost-cutting program in a statement today, which includes a reduction of 2,650 pharmaceutical sales and marketing jobs. In total, 6,300 jobs will be affected by the restructuring.
Patients taking a medication and looking online for health information tend to avoid pharmaceutical company sites, according to an online survey conducted by Accenture.
New Year's Eve is five months away, but FDA letter-writers have already been prolific in 2010 on themes of risk omission, inflated efficacy claims, and unfair balance presentation as seen in promotional materials targeting physicians and consumers.
Public service announcements featuring Tyler Walker, a 20-year-old ankylosing spondylitis (AS) patient, direct back pain sufferers to an online test created to help identify undiagnosed AS patients. The test, and published research used to validate the test, was funded by Centocor, Abbott, Amgen and Pfizer.
Generics and specialty pharma Watson acquired a progesterone gel, marketed as Crinone and Prochieve, and added roughly 19 reps to its women's health sales force. Watson now employs close to 400 reps, according to Charlie Mayr, a company spokesperson.
PhRMA said the reasoning behind a sharp cap on samples mandated by its European counterpart doesn't apply in the US.
In an effort to throttle up awareness of whooping cough, or pertussis, Sanofi Pasteur and the March of Dimes have enlisted NASCAR driver Jeff Gordon to lead their ongoing Sounds of Pertussis campaign. Jennifer Lopez was previously the celebrity face of the campaign.
Marketers working on Pfizer brands Viagra and Chantix, and AstraZeneca's Nexium, can pat themselves on the back, since they all scored in the "genius" percentile based on digital marketing competency, according to the L2 Digital IQ Index.
Following a full-scale realignment of its commercial model in 2009, Novartis will make new adjustments to its US pharmaceutical operations, including a change at the top: Ludwig Hantson, CEO and head of North American pharmaceuticals, will exit the company, a Novartis spokeswoman confirmed.
Armed with AARP and Kaiser Family research, members of the Senate Special Committee on Aging asked panelists why brand drug prices in the US continue to increase, while other countries pay half as much for the same products.
Allergan launched a celebrity Facebook campaign for Juvederm, on the heels of a new FDA approval for Juvederm XC, a formulation that contains lidocaine to make injections less painful.
While many sales jobs at large pharmaceutical companies continue to be shed amidst reorganizations, mergers and consolidations, Covidien and Biovail are bucking the trend and hiring new personnel.
Doctors using The Little Blue Book for patient referrals will be able to decide how they want to use their thumbs -- for page turning or mobile app navigation -- when a revamped edition launches next quarter.
What began as a sparkly new ad for perfume quickly shifted gears, from trivial to terrifying, once the young female actor glimpsed the perfume bottle's script: cervical cancer.
Merck will consolidate media duties on all of its brands, including the newly acquired Schering-Plough portfolio, after a review.
Sales forces for Novo Nordisk's Victoza will underscore the injectable's weight loss properties when it launches next month.
GlaxoSmithKline has put a twist on pharma's strategy of slashing sales reps to improve the earnings outlook, reallocating the positions to emerging markets.
A promotional card for Sanofi Aventis's Uroxatral omitted indication and risk information, and also used outdated product labeling, according to a DDMAC warning letter.
On Monday, Merck disclosed fees paid to US-based medical and scientific professionals who spoke at promotional medical education programs during the third quarter of 2009.